Tongee Medical Technology   

Since being founded in Hangzhou, China in 2016, Tongee's vision is to develop new ways to treat metabolic disease. Our mission is to relieve patients who suffer from metabolic diseases around the world from their pain and help them regain health and happiness. We have developed multiple new medical technologies for metabolic diseases such as obesity, type 2 diabetes, and metabolic dysfunction-associated fatty liver disease. The Gastric Bypass Stent System, an innovative Class III medical device pioneered by Tongee, has been officially approved for marketing in multiple countries both domestically and internationally, serving a wider range of minimally invasive treatment options for patients with metabolic diseases.

There remains substantial unmet clinical needs in the prevention and treatment of metabolic diseases. As a national high-tech enterprise in China, Tongee is committed to building an innovative platform for interventional gastrointestinal therapies and related medical equipment, disease management and solutions. In addition to the Gastric Bypass Stent System, Tongee is also developing a full product line for weight loss and metabolic disease treatment, including Intragastric Balloon, creating a comprehensive product matrix covering "diverse needs and all intervention stages".    

We have established multiple technology platforms and ISO13485-certified R&D, quality, manufacturing, and supply chain management system. As of December 2025, there are nearly 10 projects under development and over 150 patent applications in Tongee. Several products are undergoing clinical trials at different stages in more than 100 well-known hospitals.                 

Tongee has excellent corporate culture and talented teams. All team members adhere to the core values of “Innovation, Collaboration, Efficiency, and Dedication” and continuously enhance our professionalism, innovation and collaboration. Mr. Zuo Yuxing, the company's founder, has extensive experience in clinical medicine and commercial sales in domestic and foreign enterprises. Furthermore, the senior executive and some key team members have respectively served as vice president or head of marketing and sales in the renowned multinational medical device companies, or as human resources executive, chief technical officer, or director of clinical registration in some renowned domestic enterprises.  

Tongee is an innovation-driven and doctor- and patient-centered company dedicated to ushering in a new era of interventional treatment for metabolic diseases!